Pharming Group NV – PHAR

Pharming Group N V.

Pharming Group NV is a small cap stock with a total market cap of 745.62M.

They trade on the NASDAQ and had their IPO 2 years and 6 months

Pharming Group NV currently employs 332 people.

newspaper
News Relating to $PHAR
Proactive Investors
Tony’s or Wonka? Choc maker issues three ‘golden shares’

Wednesday May 31 2023 at 11:13

Tony’s Chocolonely, the chocolate maker, has issued three ‘golden shares’ aimed at maintaining the group’s sustainability pledge. The new governing structure is in place in case new shareholders or leadership try to steer the company away from its aim of ending inequality and exploitation in the chocolate industry.


PRNewsWire
Pharming Group to attend the following Investor Conferences in June

Thursday May 25 2023 at 02:00

LEIDEN, The Netherlands , May 25, 2023 /PRNewswire/ — Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will attend the following investor conferences in the month of June: Jefferies Healthcare Conference, New York, U.S., June 7 – 9 Pharming’s CEO, Sijmen de Vries, will present on Thursday, June 8 at 10:30 EST / 16:30 CEST.


Seeking Alpha
Pharming Group N.V. (PHGUF) Q1 2023 Earnings Call Transcript

Thursday May 11 2023 at 14:44

Pharming Group N.V. (OTCPK:PHGUF) Q1 2023 Earnings Conference Call May 11, 2023 8:30 AM ET Company Participants Sijmen de Vries – Chief Executive Officer Anurag Relan – Chief Medical Officer Stephen Toor – Chief Commercial Officer Jeroen Wakkerman – Chief Financial Officer Conference Call Participants Alistair Campbell – RBC Sushila Hernandez – VLK Simon Scholes – First Berlin Sijmen de Vries Good morning or good afternoon, ladies and gentlemen.


Zacks Investment Research
Strength Seen in Pharming Group N.V. Sponsored ADR (PHAR): Can Its 5.2% Jump Turn into More Strength?

Friday Apr 21 2023 at 06:06

Pharming Group N.V. Sponsored ADR (PHAR) witnessed a jump in share price last session on above-average trading volume.


Zacks Investment Research
Pharming (PHAR) Rare Disease Drug Joenja Gets FDA Nod, Stock Up

Monday Mar 27 2023 at 13:45

Pharming Group (PHAR) obtains FDA approval for leniolisib for the treatment of a rare pediatric disease. The stock of the company is up about 33% following the same.


Seeking Alpha
Pharming Group N.V. (PHGUF) Q4 2022 Earnings Call Transcript

Thursday Mar 16 2023 at 10:04

Pharming Group N.V. (OTCPK:PHGUF) Q4 2022 Earnings Call Transcript March 16, 2023 8:30 AM ET Company Participants Sijmen de Vries – Executive Director & Chief Executive Officer Anurag Relan – Chief Medical Officer Jeroen Wakkerman – Chief Financial Officer Stephen Toor – Chief Commercial Officer & General Manager Americas Conference Call Participants Sushila Hernandez – Kempen Joe Pantginis – H.C.


Zacks Investment Research
Why Earnings Season Could Be Great for Pharming Group (PHAR)

Tuesday Mar 14 2023 at 09:57

Pharming Group (PHAR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.


Zacks Investment Research
Pharming Group N.V. Sponsored ADR (PHAR) is on the Move, Here’s Why the Trend Could be Sustainable

Friday Jan 20 2023 at 10:32

If you are looking for stocks that are well positioned to maintain their recent uptrend, Pharming Group N.V. Sponsored ADR (PHAR) could be a great choice.


Zacks Investment Research
Pharming Group N.V. Sponsored ADR (PHAR) is on the Move, Here’s Why the Trend Could be Sustainable

Monday Dec 12 2022 at 10:32

Pharming Group N.V. Sponsored ADR (PHAR) made it through our “Recent Price Strength” screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.


Zacks Investment Research
Has Pharming Group (PHAR) Outpaced Other Medical Stocks This Year?

Thursday Dec 01 2022 at 12:03

Here is how Pharming Group N.V. Sponsored ADR (PHAR) and POINT Biopharma Global Inc. (PNT) have performed compared to their sector so far this year.

account_balance
Insider Trading

(Original Source: SEC.GOV)

Insider trading is when individuals employed by a company buy or sell its securities following legal procedures and regulations. Company executives, directors, and employees may be permitted to buy or sell shares if they follow specific rules, such as filing a Form 4 with the SEC within two business days.

help

Over the last 3 months, there has been no insider trading.

insights
Debt & Income Analysis

(Original Source: SEC.GOV)

Income quality measures a company’s operating cash flow to net income ratio. It helps investors and analysts assess the sustainability of a company’s earnings. A high QIR indicates strong cash flows, while a low QIR may indicate non-operating activities driving net income.

warning

$PHAR’s Income Quality of 0.25 is lower than its Industry Group of 0.8 (-68.8% lower)

warning

$PHAR’s Income Quality of 0.25 is lower than its Major Industry Group of 0.81 (-69.1% lower)

warning

$PHAR’s Income Quality of 0.25 is lower than its Sector of 0.83 (-69.9% lower)


(Original Source: SEC.GOV)

Current ratio measures a company’s ability to pay off short-term debt with its current assets (assets that a company expects to use up or convert to cash within a year). It represents the $ amount of current assets a company has for every $1 of short-term debt. A high current ratio above 1.0 indicates that a company can meet its short-term obligations, while a low current ratio below 1.0 suggests difficulty.

sentiment_very_satisfied

$PHAR’s Current Ratio of 4.65 is in line with its Industry Group of 4.51 (3.1% greater)

sentiment_very_satisfied

$PHAR’s Current Ratio of 4.65 is greater than its Major Industry Group of 4.13 (12.6% greater)

sentiment_very_satisfied

$PHAR’s Current Ratio of 4.65 is greater than its Sector of 2.48 (87.5% greater)

query_stats
Value Analysis

(Original Source: SEC.GOV)

PE ratio (price-to-earnings), measures a company’s stock price relative to its earnings per share. It helps investors evaluate whether its stock is overvalued or undervalued. A higher PE ratio indicates that investors are willing to pay more for a company’s earnings, while a lower PE ratio (above zero) suggests the company could be undervalued.

help

Cannot compare a negative PE Ratio (-373.74 & -1.4)

help

Cannot compare a negative PE Ratio (-373.74 & -1.22)

help

Cannot compare a negative PE Ratio (-373.74 & -0.12)


(Original Source: SEC.GOV)

The PB ratio (price-to-book), measures a company’s stock price relative to its book value (net value of a company’s assets reported on its balance sheet, after subtracting debt) per share. It is used to evaluate a company’s valuation, with a lower PB ratio (above zero) indicating a lower valuation and a higher PB ratio suggesting overvaluation.

warning

$PHAR’s PB Ratio of 3.71 is greater than its Industry Group of 1.39 (166.9% greater)

warning

$PHAR’s PB Ratio of 3.71 is greater than its Major Industry Group of 1.47 (152.4% greater)

warning

$PHAR’s PB Ratio of 3.71 is greater than its Sector of 1.7 (118.2% greater)

settings_suggest
Efficiency Analysis

(Original Source: SEC.GOV)

ROE (Return on Equity), is a financial ratio that measures a company’s profitability relative to its shareholders’ equity (the amount of value in a company that belongs to the people who own shares). It indicates how efficiently a company generates profits per unit of equity invested. A high ROE suggests effective use of equity, while a low ROE indicates inefficiency.

sentiment_very_satisfied

$PHAR’s ROE of -0.01 is greater than its Industry Group of -0.47 (97.9% greater)

sentiment_very_satisfied

$PHAR’s ROE of -0.01 is greater than its Major Industry Group of -0.41 (97.6% greater)

help

Cannot compute a percentage difference when there are zeros in the calculation


(Original Source: SEC.GOV)

ROCE (Return on Capital Employed), is a financial ratio that measures a company’s profitability relative to the amount of capital invested in its operations. It indicates how well a company is generating profits from its capital investments. A high ROCE suggests effective use of capital, while a low ROCE indicates inefficiency.

sentiment_very_satisfied

$PHAR’s ROCE of 0.01 is greater than its Industry Group of -0.43 (102.3% greater)

sentiment_very_satisfied

$PHAR’s ROCE of 0.01 is greater than its Major Industry Group of -0.38 (102.6% greater)

sentiment_very_satisfied

$PHAR’s ROCE of 0.01 is in line with its Sector of 0.01

More Stocks